HeartBeam (NASDAQ: BEAT) was featured in a recent article that discussed its development of a portable, credit-card-sized ...

Austin, Texas, United States, October 17th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT) was featured in a recent article that ...

An artificial intelligence (AI) algorithm has shown it is able to distinguish between healthy White and Black people using ...

Modern medicine’s disease diagnosis has traditionally been centered around hospitals. This is because advanced diagnostic ...

They do the same thing with planes. A [plane] has over 30,000 sensors to track everything it does, from taking off to landing ...

Chest pain is among the most common reasons for presentation to the emergency department, yet identifying patients at the ...

Faculty of Medicine and Telehealth Center, Hospital das Clínicas/EBSERH, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil (L.C.C.B., M.M.P.-F., S.M.B., B ...

AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ GuardTM, an FDA Breakthrough Device Designated AI-powered technology ...

HeartBeam's compact 3D ECG system demonstrated 94.5% accuracy in detecting arrhythmias, comparable to standard 12-lead ECGs, potentially expanding advanced cardiac monitoring to non-clinical settings.

Asystole is the most serious form of cardiac arrest. It happens when the heart stops beating and there is no more electrical activity. It is sometimes called “flat-line” or “flat-lining” because the ...

The Company continues to make significant progress towards commercial readiness, along with key clinical and regulatory achievements on the HeartBeam System. 12-Lead ECG Synthesis Software FDA ...